| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014553 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Remoxipride |
|---|
| Description | Remoxipride is only found in individuals that have used or taken this drug. It is an antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]Remoxipride acts as an antagonist at the D2 dopamine receptor. It is believed that overactivity of dopamine systems in the mesolimbic pathway may contribute to the "positive symptoms" of schizophrenia (such as delusions and hallucinations), whereas problems with dopamine function in the mesocortical pathway may be responsible for the "negative symptoms", such as avolition, flat emotional response and alogia. Therefore, by decreasing the levels of dopamine in these pathways, it is thought that remoxipride is able to reduce the symptoms of schizophrenia, particularily the "positive symptoms". |
|---|
| Structure | CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| FLA-731Roxiam | HMDB | | a-33547REmoxipride | HMDB | | Romoxipride | HMDB | | FLA-731 | HMDB | | Monohydrochloride, remoxipride | HMDB | | Remoxipride hydrochloride | HMDB | | Remoxipride monohydrochloride monohydrate | HMDB | | (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide | HMDB | | Hydrochloride anhydrous, remoxipride | HMDB | | Remoxipride monohydrochloride | HMDB | | Remoxipride monohydrochloride, (R)-isomer | HMDB | | Remoxipride, (R)-isomer | HMDB | | Remoxipride hydrochloride anhydrous | HMDB | | Anhydrous, remoxipride hydrochloride | HMDB | | Hydrochloride, remoxipride | HMDB | | Monohydrochloride monohydrate, remoxipride | HMDB |
|
|---|
| Chemical Formula | C16H23BrN2O3 |
|---|
| Average Molecular Weight | 371.269 |
|---|
| Monoisotopic Molecular Weight | 370.089205259 |
|---|
| IUPAC Name | 3-bromo-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2,6-dimethoxybenzamide |
|---|
| Traditional Name | remoxipride |
|---|
| CAS Registry Number | 80125-14-0 |
|---|
| SMILES | CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC |
|---|
| InChI Identifier | InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 |
|---|
| InChI Key | GUJRSXAPGDDABA-NSHDSACASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Methoxybenzenes |
|---|
| Direct Parent | Dimethoxybenzenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - M-dimethoxybenzene
- Dimethoxybenzene
- Halobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- Benzamide
- Benzoic acid or derivatives
- Phenoxy compound
- Anisole
- Benzoyl
- Phenol ether
- Alkyl aryl ether
- Halobenzene
- Bromobenzene
- Aryl bromide
- Aryl halide
- N-alkylpyrrolidine
- Pyrrolidine
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Ether
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organobromide
- Organic oxygen compound
- Organopnictogen compound
- Organohalogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.13 g/L | Not Available | | LogP | 2.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.66 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.3279 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.33 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 156.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1032.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 217.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 147.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 174.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 65.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 303.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 353.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 547.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 690.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 306.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 940.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 222.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 271.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 518.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 310.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 65.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 2639.4 | Semi standard non polar | 33892256 | | Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 2523.8 | Standard non polar | 33892256 | | Remoxipride,1TMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C | 3423.2 | Standard polar | 33892256 | | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 2867.1 | Semi standard non polar | 33892256 | | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 2718.8 | Standard non polar | 33892256 | | Remoxipride,1TBDMS,isomer #1 | CCN1CCC[C@H]1CN(C(=O)C1=C(OC)C=CC(Br)=C1OC)[Si](C)(C)C(C)(C)C | 3492.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Remoxipride GC-MS (Non-derivatized) - 70eV, Positive | splash10-0005-9021000000-9daaecbf42f2128e1ad4 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Remoxipride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Positive-QTOF | splash10-00di-0519000000-3d2acd15eff0b46d38f4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Positive-QTOF | splash10-03di-3912000000-e22b0c0384636903281f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Positive-QTOF | splash10-01qc-9110000000-0ddfc4805450139713b1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Negative-QTOF | splash10-014i-0029000000-cd8c03d7ed0101f27c5c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Negative-QTOF | splash10-03di-0294000000-26c857c4f2362cbb3231 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Negative-QTOF | splash10-06r6-9671000000-9edffc6cb1f1ba0b83f5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Positive-QTOF | splash10-00di-0019000000-1785aaf5dd85924ca1a4 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Positive-QTOF | splash10-00di-1329000000-f2461d27117d29c1a137 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Positive-QTOF | splash10-01oy-5790000000-c002f172028926a46b44 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 10V, Negative-QTOF | splash10-014i-0029000000-b9eb29b968cffb6427c7 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 20V, Negative-QTOF | splash10-014i-3189000000-e1209bfcec679b882747 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Remoxipride 40V, Negative-QTOF | splash10-0fbc-9072000000-004d419109fc829dd6cb | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|